Suppr超能文献

相似文献

3
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Front Pharmacol. 2017 Aug 23;8:497. doi: 10.3389/fphar.2017.00497. eCollection 2017.
5
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
J Pers Med. 2018 May 16;8(2):19. doi: 10.3390/jpm8020019.
7
Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers.
Circ Cardiovasc Qual Outcomes. 2018 Jan;11(1):e003939. doi: 10.1161/CIRCOUTCOMES.117.003939.
8
Clinical and economic challenges facing pharmacogenomics.
Pharmacogenomics J. 2013 Aug;13(4):378-88. doi: 10.1038/tpj.2011.63. Epub 2012 Jan 10.
9
Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process.
Inflamm Bowel Dis. 2019 Sep 18;25(10):1621-1628. doi: 10.1093/ibd/izz013.
10
Intergroup Contact, Prejudicial Attitudes, and Policy Preferences: The Case of the U.S. Military's "Don't Ask, Don't Tell" Policy.
J Soc Psychol. 2015 Jan-Feb;155(1):57-69. doi: 10.1080/00224545.2014.959886. Epub 2014 Nov 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验